Media Summary: Donate to PCRI: For more information, visit 0:22 What is the difference between a " Folks usually think of breast and ovarian Brian T. Helfand, MD, PhD, Chief, Division of Urology, NorthShore University HealthSystem, Evanston, Illinois, explains that ...

How Do Brca Genes Affect Prostate Cancer Risk And Treatment Prostate Health Network - Detailed Analysis & Overview

Donate to PCRI: For more information, visit 0:22 What is the difference between a " Folks usually think of breast and ovarian Brian T. Helfand, MD, PhD, Chief, Division of Urology, NorthShore University HealthSystem, Evanston, Illinois, explains that ... Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel In 2020, olaparib (Lynparza) and rucaparib (Rubraca) were FDA-approved for the UCSF oncologist Dr. Jonathan Chou discusses how

Olaparib and Rucaparib were recently approved for the Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses Why Is Genomic Profiling Key For Aggressive Find out about how some of our top researchers are aiming to use a combination of In this March 8, 2016 webinar, Susan Domchek, MD, and Justin Bekelman, MD, discussed how

Photo Gallery

How Do BRCA Genes Affect Prostate Cancer Risk And Treatment? - Prostate Health Network
Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRI
BRCA mutations and Prostate Cancer- Dr Kent DeLay
Newly Identified Germline Mutations Associated with Prostate Cancer Risk and Aggressiveness
Why Is Some Prostate Cancer Genetically Aggressive? - Prostate Health Network
BRCA Gene Testing and Prostate Cancer
Dr. Gomella Discusses Role of BRCA1/2 in Prostate Cancer
Prostate cancer team cracks genetic code to show why inherited disease can turn lethal
BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI
Understanding Prostate Cancer Mutations Is Critical
The Genetics and Genomics of Prostate Cancer
BRAC1 and BRAC2 mutations
Sponsored
Sponsored
View Detailed Profile
How Do BRCA Genes Affect Prostate Cancer Risk And Treatment? - Prostate Health Network

How Do BRCA Genes Affect Prostate Cancer Risk And Treatment? - Prostate Health Network

How

Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRI

Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRI

Donate to PCRI: https://pcri.org/donate/ For more information, visit https://pcri.org 0:22 What is the difference between a "

Sponsored
BRCA mutations and Prostate Cancer- Dr Kent DeLay

BRCA mutations and Prostate Cancer- Dr Kent DeLay

Folks usually think of breast and ovarian

Newly Identified Germline Mutations Associated with Prostate Cancer Risk and Aggressiveness

Newly Identified Germline Mutations Associated with Prostate Cancer Risk and Aggressiveness

Brian T. Helfand, MD, PhD, Chief, Division of Urology, NorthShore University HealthSystem, Evanston, Illinois, explains that ...

Why Is Some Prostate Cancer Genetically Aggressive? - Prostate Health Network

Why Is Some Prostate Cancer Genetically Aggressive? - Prostate Health Network

Why Is Some

Sponsored
BRCA Gene Testing and Prostate Cancer

BRCA Gene Testing and Prostate Cancer

BRCA gene

Dr. Gomella Discusses Role of BRCA1/2 in Prostate Cancer

Dr. Gomella Discusses Role of BRCA1/2 in Prostate Cancer

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel

Prostate cancer team cracks genetic code to show why inherited disease can turn lethal

Prostate cancer team cracks genetic code to show why inherited disease can turn lethal

Canadian and Australian

BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI

BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI

In 2020, olaparib (Lynparza) and rucaparib (Rubraca) were FDA-approved for the

Understanding Prostate Cancer Mutations Is Critical

Understanding Prostate Cancer Mutations Is Critical

The

The Genetics and Genomics of Prostate Cancer

The Genetics and Genomics of Prostate Cancer

UCSF oncologist Dr. Jonathan Chou discusses how

BRAC1 and BRAC2 mutations

BRAC1 and BRAC2 mutations

Men who carry a

BRCA Testing and Prostate Cancer Treatment Decisions | Ask a Prostate Expert, Mark Scholz, MD

BRCA Testing and Prostate Cancer Treatment Decisions | Ask a Prostate Expert, Mark Scholz, MD

Olaparib and Rucaparib were recently approved for the

Research Innovations in BRCA-Related Prostate Cancer

Research Innovations in BRCA-Related Prostate Cancer

Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses

Why Is Genomic Profiling Key For Aggressive Prostate Cancer? - Prostate Health Network

Why Is Genomic Profiling Key For Aggressive Prostate Cancer? - Prostate Health Network

Why Is Genomic Profiling Key For Aggressive

BRCA1 and BRCA2 Mutations & Cancer (Types of Cancer, and Who’s Most At Risk)

BRCA1 and BRCA2 Mutations & Cancer (Types of Cancer, and Who’s Most At Risk)

REUPLOADING TO FIX VIDEO ISSUE

BRCA Testing and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

BRCA Testing and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

PCRI's Alex asks Mark Scholz, MD, about

From Ideas to Impact: Navigating prostate cancer risks with genetics

From Ideas to Impact: Navigating prostate cancer risks with genetics

Find out about how some of our top researchers are aiming to use a combination of

BRCA Mutations in Men: What You Need to Know

BRCA Mutations in Men: What You Need to Know

In this March 8, 2016 webinar, Susan Domchek, MD, and Justin Bekelman, MD, discussed how

Gene Tests for Prostate Cancer

Gene Tests for Prostate Cancer

Treat